(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

There are several different types/causes of pulmonary fibrosis and are difficult ... The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms ...

The research is published in Nature Communications. Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which scarring of the lungs makes breathing increasingly difficult. The cause ...

Welcome to season 2 of the Medscape InDiscussion podcast series on idiopathic pulmonary fibrosis. Today we are ... that predispose but may not directly cause that may contribute, along with ...

is a progressive fibrotic lung disease of unknown cause. It remains incurable and has a poor prognosis for many patients, with a median survival of 3-5 years from diagnosis. For more information on ...

Medically reviewed by Reza Samad, MD There are two types of lung diseases: obstructive lung disease and restrictive lung ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...

The asset at play is fipaxalparant, a candidate designed to block the lysophosphatidic acid receptor 1 (LPAR1). Amgen tested ...

Pulmonary fibrosis, including its most common form, idiopathic pulmonary fibrosis ... difficult for patients to breathe. While the causes of this disease are complex and not fully understood ...

There are several different types/causes of pulmonary fibrosis and are difficult ... The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms ...